Answers are grounded in this paper and cite their sources.
Case report demonstrates successful heart transplantation outcomes under task force protocols during the COVID-19 outbreak, suggesting cardiac surgery can safely proceed.
Coronavirus disease 2019 (COVID-19) creates a challenge on donor selection, posttransplant management, and immunosuppressive therapy. A question arises about continuing heart transplantation due to risk of immunosuppressive therapy, as well as exposure during hospitalization. After the identification of the first COVID-19 patient, our center conducted the management of selection and treatment of candidates and continued to perform cardiac transplantations. Herein, we present two cases who underwent successful heart transplantation after the determination of patient zero in Türkiye to highlight clinical implications by describing our clinical principle in the ethical knowledge of the International Society for Heart and Lung Transplantation COVID-19 task force statement regarding heart transplantation.
No takes yet. Share an insight, caveat, or question.
Özge Altaş (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: